Back to top

Bank of America Securities Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)

Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Syndax Pharmaceuticals today and set a price target of $29.00. Accordi...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Syndax Pharmaceuticals, Inc. (SNDX)